1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-100903 Norbinaltorphimine dihydrochloride

Opioid Receptor

Neurological Disease

2020-04 Norbinaltorphimine dihydrochloride
HY-10968 CYM5442

LPL Receptor

Neurological Disease

2020-04 CYM5442
HY-100504 S-methyl DM1

Microtubule/Tubulin

Cancer

2020-04 S-methyl DM1
HY-128365 Neticonazole hydrochloride

Fungal

Cancer;

Infection

2020-04 Neticonazole hydrochloride
HY-B0976 Fenoterol

Adrenergic Receptor

Endocrinology;

Inflammation/Immunology

2020-04 Fenoterol
HY-135859 NH2-MPAA-NODA

Others

Cancer

2020-04 NH2-MPAA-NODA
HY-14470 Sibutramine hydrochloride monohydrate

Serotonin Transporter; Potassium Channel

Metabolic Disease;

Neurological Disease

2020-04 Sibutramine hydrochloride monohydrate
HY-B0661 Tamsulosin

Adrenergic Receptor

Endocrinology;

Neurological Disease

2020-04 Tamsulosin
HY-12769 Mebeverine acid

Drug Metabolite

Others

2020-04 Mebeverine acid
HY-124047 RX 67668

AChE

Neurological Disease

2020-04 RX 67668
HY-130852 CDK9-IN-11

CDK; Ligand for Target Protein for PROTAC

Cancer

2020-04 CDK9-IN-11
HY-101759 Isoxsuprine-monoester-1

Others

Cardiovascular Disease

2020-04 Isoxsuprine-monoester-1
HY-15421 6-Iodopravadoline

Cannabinoid Receptor

Neurological Disease

2020-04 6-Iodopravadoline
HY-12771 O-desmethyl Mebeverine acid

Drug Metabolite

Others

2020-04 O-desmethyl Mebeverine acid
HY-75766S Methylnaltrexone D3 Bromide

Opioid Receptor

Others

2020-04 Methylnaltrexone D3 Bromide
HY-101939 RP-001

LPL Receptor

Neurological Disease

2020-04 RP-001
HY-B0554 Norethindrone

Progesterone Receptor

Endocrinology

2020-04 Norethindrone
HY-A0078S Mebeverine D6 Hydrochloride

Adrenergic Receptor

Endocrinology;

Others

2020-04 Mebeverine D6 Hydrochloride
HY-12770S Mebeverine alcohol D5

Others

Others

2020-04 Mebeverine alcohol D5
HY-113368 3b,17b-Dihydroxyetiocholane

Endogenous Metabolite

Metabolic Disease

2020-04 3b,17b-Dihydroxyetiocholane